RXO (NYSE:RXO) Upgraded to “Outperform” at Citizens Jmp

Citizens Jmp upgraded shares of RXO (NYSE:RXOFree Report) from a market perform rating to an outperform rating in a research note released on Friday, MarketBeat.com reports. They currently have $30.00 price objective on the stock.

Several other analysts also recently weighed in on RXO. Morgan Stanley restated an “equal weight” rating and set a $22.00 target price (up from $19.00) on shares of RXO in a research note on Thursday, May 7th. The Goldman Sachs Group lifted their price target on RXO from $18.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, July 16th. Weiss Ratings raised RXO from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, June 4th. Stifel Nicolaus raised their price objective on shares of RXO from $22.00 to $30.00 and gave the stock a “buy” rating in a research note on Monday, July 13th. Finally, Barclays boosted their target price on shares of RXO from $20.00 to $28.00 and gave the stock an “overweight” rating in a research report on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $23.85.

Read Our Latest Research Report on RXO

RXO Price Performance

NYSE RXO opened at $21.79 on Friday. RXO has a 52-week low of $10.43 and a 52-week high of $29.90. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a market capitalization of $3.59 billion, a price-to-earnings ratio of -35.72 and a beta of 2.10. The company has a 50 day simple moving average of $26.10 and a 200-day simple moving average of $20.09.

RXO (NYSE:RXOGet Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The firm had revenue of $1.77 billion during the quarter, compared to analysts’ expectations of $1.63 billion. RXO had a negative return on equity of 0.98% and a negative net margin of 1.72%.The business’s revenue for the quarter was up 25.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.04 earnings per share. Equities research analysts predict that RXO will post 0.08 earnings per share for the current fiscal year.

Institutional Investors Weigh In On RXO

A number of hedge funds have recently added to or reduced their stakes in RXO. Royal Bank of Canada raised its stake in shares of RXO by 14.3% during the first quarter. Royal Bank of Canada now owns 23,251 shares of the company’s stock worth $444,000 after buying an additional 2,902 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in RXO by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 94,940 shares of the company’s stock valued at $1,813,000 after acquiring an additional 4,134 shares during the last quarter. Geneos Wealth Management Inc. bought a new position in RXO in the first quarter valued at approximately $30,000. Strs Ohio acquired a new stake in RXO during the 1st quarter worth $97,000. Finally, Quantbot Technologies LP acquired a new stake in RXO during the 2nd quarter worth $245,000. Institutional investors own 92.73% of the company’s stock.

Trending Headlines about RXO

Here are the key news stories impacting RXO this week:

  • Positive Sentiment: RXO highlighted market-share gains and profitable volume growth, including a 2% increase in truckload brokerage volume and a record sequential improvement in gross profit per load. Market Share Gains and Improved Profitability Drive Strong Second-Quarter Results for RXO
  • Positive Sentiment: The earnings and revenue beats, along with stronger-than-expected operating metrics, helped drive investor enthusiasm and a positive premarket reaction. RXO Q2 Earnings and Revenues Surpass Estimates
  • Positive Sentiment: Citizens JMP upgraded RXO from “market perform” to “outperform” and set a $30 price target, while Truist maintained a “buy” rating with a $28 target, both implying meaningful potential upside. Analyst Ratings
  • Neutral Sentiment: Citi lowered its price target from $30 to $23 and shifted to a “neutral” rating, reflecting more cautious expectations despite the quarterly beat. Citi Analyst Action
  • Negative Sentiment: Some analysis argues that RXO’s strong revenue growth was driven largely by higher freight rates and fuel prices, while gross profit declined and adjusted EBITDA remained flat. Rising working-capital requirements and leverage also raise concerns about the quality and durability of the recovery. RXO Still Unable To Capture Upcycle Economics

RXO Company Profile

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Featured Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.